热门资讯> 正文

周六报道，Teva报告称，患有迟发性运动障碍的患者发现AUSTEDO XR易于服用，同意率超过96%

2025-09-22 14:50

Of the 209 patients with tardive dyskinesia (TD) that were surveyed, >94% reported movement improvement once treated with AUSTEDO XR® (deutetrabenazine) extended-release tablets
Patients reported high satisfaction (>89%) with AUSTEDO XR, with 96% expressing interest in continuing treatment
Almost all (>96%) patients relayed that AUSTEDO XR was easy to take

推荐文章

风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。